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Involvement of the endosomal autoantigen EEA1 in homotypic
fusion of early endosomes
Ian G. Mills, Arwyn T. Jones* and Michael J. Clague
In mammalian cells, fusion between early endocytic
vesicles has been shown to require the ubiquitous
intracellular fusion factors N-ethylmaleimide-sensitive
factor (NSF) and a-SNAP, as well as a factor specific for
early endosomes, the small GTPase Rab5 [1–3]. We
have previously demonstrated an additional
requirement for phosphatidylinositol 3-kinase (PI
3-kinase) activity [4]. The membrane association of
early endosomal antigen 1 (EEA1), a specific marker of
early endosomes [5,6], has recently been shown to be
similarly dependent on PI 3-kinase activity [7], and we
therefore postulated that it might be involved in
endosome fusion. Here, we present evidence that EEA1
has an important role in determining the efficiency of
endosome fusion in vitro. Both the carboxy-terminal
domain of EEA1 (residues 1098–1411) and specific
antibodies against EEA1 inhibited endosome fusion
when included in an in vitro assay. Furthermore,
depletion of EEA1, both from the membrane fraction
used in the assay by washing with salt and from the
cytosol using an EEA1-specific antibody, resulted in
inhibition of endosome fusion. The involvement of
EEA1 in endosome fusion accounts for the sensitivity of
the endosome fusion assay to inhibitors of PI 3-kinase. 
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Results and discussion
We checked that EEA1 redistributes from the early endo-
somes of baby hamster kidney (BHK) cells upon inhibition
of PI 3-kinase by wortmannin, as has been shown for other
cell types using crude membrane preparations [7]. To gen-
erate an enriched early endosomal fraction and separate
early endosomes from late endosomes, we used an estab-
lished protocol involving a sucrose flotation gradient [3].
We observed that EEA1 was absent in an early endosomal
fraction from wortmannin-treated cells (Figure 1a),
whereas another peripheral marker of early endosomes,
the small GTPase Rab5, remained in place (Figure 1b).
In order to test if EEA1 is necessary for endosome
fusion, polyclonal rabbit antibodies raised against the
bacterially expressed carboxy-terminal fragments of
EEA1 encompassed by residues 723–1411 and
1098–1411 —EEA1(723–1411) and EEA1(1098–1411),
respectively — were pre-incubated with postnuclear
fractions, which were then combined, with the antibody
still present, in an in vitro assay for endosome fusion.
Both antisera provided a significant inhibition of fusion
(Figure 2a). A minimal effect was observed when control
serum was used instead of the anti-EEA1 antibodies.
The serum raised against EEA1(1098–1411) was affinity
purified using antigen, and the flow through from the
column was included in a fusion assay (Figure 2a). The
inhibitory activity of this residual serum was the same as
that of control serum, indicating that the inhibitory effect
is specific to components that recognise the antigen. As
expected, the affinity purified antibody from this column
inhibited fusion (Figure 2a). We also conducted a fusion
assay using membranes isolated from postnuclear frac-
tions that had been exposed to the anti-EEA1(723–1411)
antibody, facilitating the removal of antibody before frac-
tions were combined. This gave less inhibition than
when antibody was included in the final fusion step of
the assay (Figure 2b), in accord with there being a signif-
icant pool of EEA1 in the rat brain cytosol used to
support the fusion of isolated membranes. Interestingly,
Figure 1
EEA1 dissociates from early endosomes following wortmannin
treatment. Post-nuclear supernatants were prepared from untreated
cells or cells pre-incubated with 100 nM wortmannin. In each case, a
fraction enriched for early endosomes was isolated on a sucrose
flotation gradient as described by Gorvel et al. [3] and 5 µg was
analysed by western blotting for either (a) EEA1 or (b) Rab5. EEA1 is
completely absent from the fraction isolated from wortmannin-treated
cells, whereas the level of Rab5 is similar in fractions from treated and
untreated cells.
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exposure to the antisera of only one of the two mem-
brane fractions combined in this fusion assay was virtu-
ally as effective as exposure of both (Figure 2b).
We purified EEA1(1098–1411) from bacteria; this frag-
ment contains a FYVE zinc finger domain and is sufficient
for endosomal localisation [6]. Inclusion of this protein
also exerted an inhibitory effect on endosome fusion in
vitro (Figure 3a). This implies that the amino-terminal
domain of EEA1, which is missing from the added frag-
ment, has an important role in endosome fusion, as the
carboxy-terminal domain associated with endosomes and
displaced endogenous wild-type protein over the same
concentration range (Figure 3b). The inhibition was
insensitive to supplementation of the assay with ZnCl2
indicating that it is not due to zinc chelation by
EEA1(1098–1411) [8] (data not shown).
In our hands, the majority of EEA1 in BHK-21 cells was
associated with the membrane fraction, although a signifi-
cant cytosolic fraction was present (Figure 4a). EEA1 asso-
ciation with the membrane fraction could be completely
disrupted by incubation with 0.3 M NaCl (Figure 4a). At
the concentration of rat brain cytosol we have used in the
fusion assay, salt washing resulted in a reduction in endo-
some fusion (Figure 4c). When we immunodepleted rat
brain cytosol using polyclonal antibodies (Figure 4b) in
addition to salt washing the membranes, we found that
endosome fusion was reduced even further (Figure 4c).
Using immunodepleted cytosol and untreated membranes
also resulted in a specific reduction in fusion, similar to
that obtained by salt treatment alone. Under our standard
conditions of endosome fusion supported by rat brain
cytosol in vitro, we estimate from western blot analysis
that roughly equal amounts of EEA1 are supplied by the
membrane fractions and the cytosol. The reduction in
fusion corresponding to salt washing is consistent with
EEA1 removal but cannot be directly attributed to it as
other factors might also have been removed. The reduc-
tion in fusion due to immunodepletion, however, is clearly
specific for the removal of EEA1 and any factors which
may be associated with it.
In this report we have provided a body of evidence in
support of a role of EEA1 in endosome fusion, a role that
we initially postulated on the basis of its redistribution fol-
lowing wortmannin treatment. It has previously been pro-
posed that activation of the small GTPase Rab5 may
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Figure 3
Recombinant EEA1(1098–1411) reduces endosomal fusion efficiency
and displaces endogenous EEA1 from membranes. (a) Varying
amounts of His6-tagged EEA1(1098–1411) were added in a standard
fusion assay (volume, 220 µl; protein concentration, 4 mg/ml). Fusion is
expressed as a proportion of that obtained in a control incubation in
which no fragment was added. (b) Membranes incubated with the
indicated amounts of the recombinant fragment, under fusion assay
conditions, were isolated from the cytosol and each fraction was
analysed for endogenous EEA1 by western blot. Displacement of EEA1
from membranes to cytosol was observed over the same concentration
range of EEA1(1098–1411) required for inhibition of fusion.
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Figure 2
Antibodies against EEA1 inhibit endosome fusion. In the endosome
fusion assay used, which measures contents mixing, one set of
endosomes were labelled with avidin and the other with biotin
conjugated to horse radish peroxidase (HRP). (a) Both of the
postnuclear supernatants combined in the assay were either left
untreated (–) or pre-incubated with 5 µl of the indicated rabbit antisera,
an equivalent amount of flow through from an affinity column used to
purify anti-EEA1(1098–1411) antibody, or 15 µg of this affinity purified
antibody. The fusion efficiencies were normalised to the signal
obtained using untreated controls. (b) Exposure to antiserum of only
one of two sets of membrane fractions combined in a fusion assay is
sufficient for inhibition. For this experiment, rather than combine
postnuclear supernatants, membranes isolated from these
supernatants were combined and fusion was supported by rat brain
cytosol. This enabled us to allow antibodies to have access to only one
of the two sets of membranes used in the fusion assay. We either left
both membrane fractions untreated (–), pre-incubated both the avidin-
labelled and biotin–HRP-labelled fractions with 5 µl anti-
EEA1(723–1411) antiserum, pre-incubated only the avidin fraction
with the antiserum or added the antiserum to the complete fusion mix.
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represent the requirement of PI 3-kinase activity for endo-
some fusion [9]. Recent data from our laboratory have
shown that PI 3-kinase activity is required for an effector
action other than activation of Rab5, however, because
wortmannin inhibition of endosome fusion is still
observed in the presence of a moderate excess of activated
Rab5 or GTPγS, which causes constitutive activation of
small GTPases [10]. In the presence of a vast excess of
activated Rab5, endosome fusion in our assay becomes
insensitive to wortmannin. The magnitude of the inhibi-
tion of endosome fusion that we observe with each manip-
ulation of EEA1 suggests that wortmannin inhibition of
endosome fusion can be fully accounted for by its effect
on the distribution of EEA1. In a report of a recent
meeting [11], data showing an interaction between Rab5
and EEA1 are discussed. It could be that in the presence
of a large excess of Rab5, a relatively low affinity interac-
tion with EEA1 is sufficient to localise it to endosomes.
This interaction may be required under all conditions for
endosome fusion as it is clear that Rab5 [3] and, from our
observations, EEA1 are required for endosome fusion.
Under native conditions and at lower levels of Rab5, it is
conceivable that the interaction is favoured by the accu-
mulation of EEA1 and Rab5 to early endosomes by virtue
of PI 3-phosphate and prenylation-dependent membrane
associations, respectively. Rabaptin-5 has also been identi-
fied as an effector of Rab5 and a complex of this protein
with another protein, Rabex-5, is essential for endosome
fusion [12]. The relationship between these proteins and
EEA1 on the fusion pathway must now be determined.
Materials and methods
Materials
Polyclonal rabbit antisera raised against EEA1(723–1411) were the
kind gift of M. Renz. The cDNA corresponding to EEA1(1098–1411)
was inserted into a pTric-HisA vector. Bacterially expressed His6-
tagged protein was purified using Ni2+ affinity chromatography fol-
lowed by dialysis against 50 mM Tris, 1 µM ZnCl2, pH 7.4.
Cell-free fusion assay
Internalisation of avidin and biotin–HRP into BHK-21 cells was carried
out essentially as described previously [3,13]. In the standard configu-
ration of the assay, postnuclear fractions were combined in a mixture
also containing salts, buffers, biotin–insulin and an ATP-regenerating
system as described by Gorvel et al. [3]. Alternatively, membranes
were prepared by pelleting at 65,000 rpm (using a TLA 100.2 rotor) for
15 min and combined in a fusion assay supplemented with rat brain
cytosol or BHK cytosol, a process that allows specific interventions to
be made on these components before they are combined. This mixture
was then incubated at 37°C for 30 min before lysis on ice with 0.2%
Triton X-100. Fusion efficiency was measured by immunoprecipitation
of avidin followed by determination of bound HRP.
Immunodepletion
Rat brain cytosol prepared by the method of Waters et al. [14] was
incubated with end-over-end rotation at 4°C for 2 h together with EEA1
polyclonal serum pre-absorbed onto protein-A–sepharose. The anti-
body-coated beads were removed and replaced with a fresh batch for
a further 2 h incubation before removal and collection of the cytosol.
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Figure 4
Reduced endosome fusion efficiency correlates with EEA1 depletion.
(a) Western blot showing removal of EEA1 from BHK membranes by
0.3 M NaCl. Postnuclear supernatants were incubated with or without
salt at 4°C and then membrane (30 µg) and cytosol (80 µg) fractions,
separated as described in Materials and methods, were analysed for
the presence of EEA1. (b) Western blot showing immunodepletion of
EEA1 from rat brain cytosol using anti-EEA1(1098–1411) antibody;
100 µg protein was loaded per lane. As a control, cytosol was treated
with serum from a non-immunised rabbit absorbed onto
protein-A–sepharose. (c) Early endosome fusion assay as described in
Materials and methods. Membranes were isolated following incubation
with or without 0.3 M NaCl and recombined with one of the two rat
brain cytosol fractions shown in (b).
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